| 0 |
ACHLORHYDRIA |
1 |
0.0143 |
| 1 |
SMALL CELL LUNG CANCER EXTENSIVE STAGE |
1 |
0.0087 |
| 2 |
IMPLANT SITE VESICLES |
1 |
0.0068 |
| 3 |
TOOTH DEVELOPMENT DISORDER |
1 |
0.0068 |
| 4 |
SENSORY PROCESSING DISORDER |
1 |
0.0059 |
| 5 |
METASTASES TO RETROPERITONEUM |
1 |
0.0059 |
| 6 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
5 |
0.0047 |
| 7 |
PRODUCT INTOLERANCE |
1 |
0.0045 |
| 8 |
SCLERAL DISORDER |
1 |
0.0037 |
| 9 |
ENAMEL ANOMALY |
1 |
0.0035 |
| 10 |
CREUTZFELDT-JAKOB DISEASE |
1 |
0.0035 |
| 11 |
IMPLANT SITE EROSION |
1 |
0.0034 |
| 12 |
BLOOD BILIRUBIN DECREASED |
2 |
0.0032 |
| 13 |
VENOUS PRESSURE JUGULAR INCREASED |
1 |
0.0028 |
| 14 |
DIET NONCOMPLIANCE |
1 |
0.0027 |
| 15 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 16 |
ARACHNOID CYST |
1 |
0.0025 |
| 17 |
BONE ABSCESS |
1 |
0.0025 |
| 18 |
VIRAL RASH |
1 |
0.0025 |
| 19 |
METASTASES TO THE MEDIASTINUM |
1 |
0.0024 |
| 20 |
BONE INFARCTION |
1 |
0.0022 |
| 21 |
ELECTROLYTE DEPLETION |
1 |
0.0020 |
| 22 |
DYSPRAXIA |
1 |
0.0018 |
| 23 |
LIFE EXPECTANCY SHORTENED |
1 |
0.0018 |
| 24 |
MOTOR DEVELOPMENTAL DELAY |
1 |
0.0017 |
| 25 |
CRYSTAL NEPHROPATHY |
1 |
0.0017 |
| 26 |
INHALATION THERAPY |
1 |
0.0016 |
| 27 |
NEPHROGENIC ANAEMIA |
7 |
0.0015 |
| 28 |
DIET REFUSAL |
1 |
0.0014 |
| 29 |
CENTRAL OBESITY |
1 |
0.0014 |
| 30 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0013 |
| 31 |
WOUND DRAINAGE |
1 |
0.0013 |
| 32 |
HEMIANAESTHESIA |
1 |
0.0013 |
| 33 |
HYPERPARATHYROIDISM SECONDARY |
3 |
0.0012 |
| 34 |
HEPATIC CANCER METASTATIC |
1 |
0.0012 |
| 35 |
TONGUE MOVEMENT DISTURBANCE |
1 |
0.0012 |
| 36 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 37 |
STEREOTYPY |
1 |
0.0011 |
| 38 |
PCO2 DECREASED |
1 |
0.0010 |
| 39 |
TRAUMATIC LUNG INJURY |
2 |
0.0010 |
| 40 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 41 |
IMPLANT SITE ERYTHEMA |
1 |
0.0010 |
| 42 |
HYDROCELE |
1 |
0.0009 |
| 43 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 44 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 45 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 46 |
WEIGHT ABNORMAL |
2 |
0.0008 |
| 47 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 48 |
PANCREATIC NEOPLASM |
1 |
0.0008 |
| 49 |
IATROGENIC INJURY |
1 |
0.0008 |
| 50 |
SLOW RESPONSE TO STIMULI |
1 |
0.0008 |
| 51 |
VOMITING PROJECTILE |
2 |
0.0007 |
| 52 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 53 |
APRAXIA |
1 |
0.0007 |
| 54 |
INTELLECTUAL DISABILITY |
1 |
0.0007 |
| 55 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 56 |
PROCTALGIA |
4 |
0.0006 |
| 57 |
GASTROINTESTINAL SOUNDS ABNORMAL |
3 |
0.0006 |
| 58 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 59 |
KYPHOSIS |
1 |
0.0006 |
| 60 |
VOCAL CORD PARALYSIS |
1 |
0.0006 |
| 61 |
RADIOTHERAPY |
1 |
0.0005 |
| 62 |
OCCULT BLOOD POSITIVE |
1 |
0.0005 |
| 63 |
PHYSICAL ASSAULT |
1 |
0.0005 |
| 64 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 65 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 66 |
IMPLANT SITE INFECTION |
1 |
0.0004 |
| 67 |
CONTRAST MEDIA REACTION |
1 |
0.0004 |
| 68 |
ORAL INTAKE REDUCED |
1 |
0.0004 |
| 69 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 70 |
END STAGE RENAL DISEASE |
7 |
0.0004 |
| 71 |
ANAL FISSURE |
2 |
0.0004 |
| 72 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 73 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 74 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 75 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 76 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 77 |
PULMONARY PAIN |
1 |
0.0003 |
| 78 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 79 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 80 |
SELF INJURIOUS BEHAVIOUR |
1 |
0.0003 |
| 81 |
BRAIN DEATH |
1 |
0.0003 |
| 82 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 83 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 84 |
EAR PRURITUS |
1 |
0.0003 |
| 85 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 86 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 87 |
APPENDICECTOMY |
1 |
0.0003 |
| 88 |
TONGUE OEDEMA |
1 |
0.0003 |
| 89 |
SPINAL CORD COMPRESSION |
1 |
0.0003 |
| 90 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 91 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
0.0002 |
| 92 |
INTERNATIONAL NORMALISED RATIO DECREASED |
1 |
0.0002 |
| 93 |
HOMICIDAL IDEATION |
1 |
0.0002 |
| 94 |
ABNORMAL FAECES |
2 |
0.0002 |
| 95 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 96 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 97 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 98 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 99 |
YELLOW SKIN |
1 |
0.0002 |
| 100 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 101 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 102 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 103 |
MALABSORPTION |
1 |
0.0002 |
| 104 |
RENAL PAIN |
2 |
0.0002 |
| 105 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 106 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 107 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 108 |
ASPIRATION |
2 |
0.0002 |
| 109 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 110 |
CHOKING SENSATION |
1 |
0.0002 |
| 111 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 112 |
MALNUTRITION |
2 |
0.0002 |
| 113 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 114 |
FISTULA |
2 |
0.0002 |
| 115 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 116 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 117 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 118 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 119 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 120 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 121 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 122 |
BRAIN OEDEMA |
2 |
0.0002 |
| 123 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 124 |
INCOHERENT |
1 |
0.0002 |
| 125 |
RASH GENERALISED |
4 |
0.0002 |
| 126 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 127 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 128 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 129 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 130 |
DROOLING |
1 |
0.0001 |
| 131 |
EXTRASYSTOLES |
1 |
0.0001 |
| 132 |
PAPULE |
1 |
0.0001 |
| 133 |
DIVERTICULUM |
1 |
0.0001 |
| 134 |
ARTHROPOD BITE |
1 |
0.0001 |
| 135 |
ACIDOSIS |
1 |
0.0001 |
| 136 |
LIPASE INCREASED |
1 |
0.0001 |
| 137 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 138 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 139 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 140 |
PELVIC FRACTURE |
1 |
0.0001 |
| 141 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 142 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 143 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 144 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 145 |
FURUNCLE |
1 |
0.0001 |
| 146 |
RENAL CYST |
1 |
0.0001 |
| 147 |
ABSCESS |
2 |
0.0001 |
| 148 |
STENT PLACEMENT |
1 |
0.0001 |
| 149 |
ASPHYXIA |
1 |
0.0001 |
| 150 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 151 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 152 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 153 |
EMBOLISM |
1 |
0.0001 |
| 154 |
HEMIPLEGIA |
1 |
0.0001 |
| 155 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 156 |
ABDOMINAL DISTENSION |
12 |
0.0001 |
| 157 |
EOSINOPHILIA |
2 |
0.0001 |
| 158 |
APPENDICITIS |
1 |
0.0001 |
| 159 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 160 |
SPINAL DISORDER |
1 |
0.0001 |
| 161 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 162 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 163 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 164 |
HOSPICE CARE |
1 |
0.0001 |
| 165 |
RENAL INJURY |
3 |
0.0001 |
| 166 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 167 |
HYPOTONIA |
1 |
0.0001 |
| 168 |
OVARIAN CYST |
1 |
0.0001 |
| 169 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 170 |
AGGRESSION |
5 |
0.0001 |
| 171 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 172 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 173 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 174 |
EATING DISORDER |
2 |
0.0001 |
| 175 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 176 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 177 |
RENAL FAILURE |
12 |
0.0001 |
| 178 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 179 |
FOOT DEFORMITY |
1 |
0.0001 |
| 180 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 181 |
ORAL PAIN |
2 |
0.0001 |
| 182 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 183 |
FIBROMYALGIA |
2 |
0.0001 |
| 184 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 185 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 186 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 187 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 188 |
HAEMATEMESIS |
2 |
0.0001 |
| 189 |
THERAPY CESSATION |
4 |
0.0001 |
| 190 |
SKIN ULCER |
2 |
0.0001 |
| 191 |
HIATUS HERNIA |
1 |
0.0001 |
| 192 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 193 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 194 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 195 |
VOMITING |
34 |
0.0001 |
| 196 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 197 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 198 |
HAEMOPTYSIS |
2 |
0.0001 |
| 199 |
PANCYTOPENIA |
4 |
0.0001 |
| 200 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 201 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 202 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 203 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 204 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 205 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 206 |
COLON CANCER |
1 |
0.0001 |
| 207 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 208 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 209 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 210 |
ACUTE KIDNEY INJURY |
10 |
0.0001 |
| 211 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 212 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 213 |
LUNG INFECTION |
1 |
0.0001 |
| 214 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 215 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 216 |
CYANOSIS |
1 |
0.0001 |
| 217 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 218 |
MOOD SWINGS |
2 |
0.0001 |
| 219 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 220 |
MANIA |
1 |
0.0001 |
| 221 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 222 |
URINARY RETENTION |
2 |
0.0001 |
| 223 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 224 |
CHILLS |
7 |
0.0001 |
| 225 |
ANGER |
2 |
0.0001 |
| 226 |
HAEMATURIA |
2 |
0.0001 |
| 227 |
DELIRIUM |
2 |
0.0001 |
| 228 |
PANCREATITIS |
3 |
0.0001 |
| 229 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 230 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 231 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 232 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 233 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 234 |
BLISTER |
3 |
0.0001 |
| 235 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 236 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 237 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 238 |
FLATULENCE |
3 |
0.0001 |
| 239 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 240 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 241 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 242 |
HERNIA |
1 |
0.0001 |
| 243 |
ERUCTATION |
1 |
0.0001 |
| 244 |
CHOKING |
1 |
0.0001 |
| 245 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 246 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 247 |
CONSTIPATION |
11 |
0.0001 |
| 248 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
10 |
0.0000 |
| 249 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 250 |
TREMOR |
8 |
0.0000 |
| 251 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 252 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 253 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 254 |
SKIN CANCER |
1 |
0.0000 |
| 255 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 256 |
SEPTIC SHOCK |
2 |
0.0000 |
| 257 |
MENTAL DISORDER |
2 |
0.0000 |
| 258 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 259 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 260 |
CHROMATURIA |
1 |
0.0000 |
| 261 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 262 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 263 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 264 |
PNEUMONIA |
14 |
0.0000 |
| 265 |
RENAL DISORDER |
2 |
0.0000 |
| 266 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 267 |
ARRHYTHMIA |
2 |
0.0000 |
| 268 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 269 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 270 |
PRESYNCOPE |
1 |
0.0000 |
| 271 |
HYPOPHAGIA |
1 |
0.0000 |
| 272 |
HEPATITIS |
1 |
0.0000 |
| 273 |
HYPERHIDROSIS |
5 |
0.0000 |
| 274 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 275 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 276 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 277 |
SPEECH DISORDER |
2 |
0.0000 |
| 278 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 279 |
EAR INFECTION |
1 |
0.0000 |
| 280 |
DEHYDRATION |
5 |
0.0000 |
| 281 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 282 |
PALLOR |
1 |
0.0000 |
| 283 |
PNEUMONITIS |
1 |
0.0000 |
| 284 |
DIVERTICULITIS |
1 |
0.0000 |
| 285 |
FEELING COLD |
1 |
0.0000 |
| 286 |
INFLUENZA |
4 |
0.0000 |
| 287 |
WOUND |
1 |
0.0000 |
| 288 |
HYPONATRAEMIA |
2 |
0.0000 |
| 289 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 290 |
NAUSEA |
28 |
0.0000 |
| 291 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 292 |
ANGINA PECTORIS |
1 |
0.0000 |
| 293 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 294 |
DYSSTASIA |
1 |
0.0000 |
| 295 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 296 |
NASAL CONGESTION |
2 |
0.0000 |
| 297 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 298 |
HEPATIC FAILURE |
1 |
0.0000 |
| 299 |
APHASIA |
1 |
0.0000 |
| 300 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 301 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 302 |
DISCOMFORT |
2 |
0.0000 |
| 303 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 304 |
CYSTITIS |
1 |
0.0000 |
| 305 |
NIGHT SWEATS |
1 |
0.0000 |
| 306 |
CHOLELITHIASIS |
1 |
0.0000 |
| 307 |
DYSPEPSIA |
3 |
0.0000 |
| 308 |
HEART RATE INCREASED |
3 |
0.0000 |
| 309 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 310 |
LIP SWELLING |
1 |
0.0000 |
| 311 |
FUNGAL INFECTION |
1 |
0.0000 |
| 312 |
EYE PRURITUS |
1 |
0.0000 |
| 313 |
FLUSHING |
3 |
0.0000 |
| 314 |
ASTHENIA |
11 |
0.0000 |
| 315 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 316 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 317 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 318 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 319 |
BURNING SENSATION |
2 |
0.0000 |
| 320 |
HYPERKALAEMIA |
1 |
0.0000 |
| 321 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 322 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 323 |
MOBILITY DECREASED |
2 |
0.0000 |
| 324 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 325 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 326 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 327 |
RESTLESSNESS |
1 |
0.0000 |
| 328 |
AGITATION |
2 |
0.0000 |
| 329 |
HYPOAESTHESIA |
4 |
0.0000 |
| 330 |
HOT FLUSH |
2 |
0.0000 |
| 331 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 332 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 333 |
DISORIENTATION |
1 |
0.0000 |
| 334 |
CARDIAC FAILURE |
2 |
0.0000 |
| 335 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 336 |
DYSKINESIA |
1 |
0.0000 |
| 337 |
OSTEOPOROSIS |
1 |
0.0000 |
| 338 |
POLLAKIURIA |
1 |
0.0000 |
| 339 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 340 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 341 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 342 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 343 |
THROAT IRRITATION |
1 |
0.0000 |
| 344 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 345 |
CHEST PAIN |
4 |
0.0000 |
| 346 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 347 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 348 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 349 |
DYSPHAGIA |
2 |
0.0000 |
| 350 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 351 |
COMA |
1 |
0.0000 |
| 352 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 353 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 354 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 355 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 356 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 357 |
LUNG DISORDER |
1 |
0.0000 |
| 358 |
ALOPECIA |
4 |
0.0000 |
| 359 |
PYREXIA |
7 |
0.0000 |
| 360 |
HYPOTENSION |
4 |
0.0000 |
| 361 |
CELLULITIS |
1 |
0.0000 |
| 362 |
FLUID RETENTION |
1 |
0.0000 |
| 363 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 364 |
HOSPITALISATION |
3 |
0.0000 |
| 365 |
DYSPNOEA |
11 |
0.0000 |
| 366 |
ILLNESS |
2 |
0.0000 |
| 367 |
INFLAMMATION |
1 |
0.0000 |
| 368 |
HAEMORRHAGE |
2 |
0.0000 |
| 369 |
PARAESTHESIA |
3 |
0.0000 |
| 370 |
DEPRESSED MOOD |
1 |
0.0000 |
| 371 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 372 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 373 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 374 |
FATIGUE |
14 |
0.0000 |
| 375 |
SEPSIS |
2 |
0.0000 |
| 376 |
URTICARIA |
3 |
0.0000 |
| 377 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 378 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 379 |
MYALGIA |
3 |
0.0000 |
| 380 |
HEADACHE |
11 |
0.0000 |
| 381 |
EYE IRRITATION |
1 |
0.0000 |
| 382 |
SEIZURE |
2 |
0.0000 |
| 383 |
DECREASED APPETITE |
4 |
0.0000 |
| 384 |
DYSPHONIA |
1 |
0.0000 |
| 385 |
DIARRHOEA |
11 |
0.0000 |
| 386 |
WHEEZING |
1 |
0.0000 |
| 387 |
IRRITABILITY |
1 |
0.0000 |
| 388 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 389 |
FEELING HOT |
1 |
0.0000 |
| 390 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 391 |
ANAEMIA |
3 |
0.0000 |
| 392 |
RHINORRHOEA |
1 |
0.0000 |
| 393 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 394 |
AMNESIA |
1 |
0.0000 |
| 395 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 396 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 397 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 398 |
FALL |
5 |
0.0000 |
| 399 |
INSOMNIA |
4 |
0.0000 |
| 400 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 401 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 402 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 403 |
COUGH |
4 |
0.0000 |
| 404 |
INJURY |
1 |
0.0000 |
| 405 |
SLEEP DISORDER |
1 |
0.0000 |
| 406 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 407 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 408 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 409 |
EPISTAXIS |
1 |
0.0000 |
| 410 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 411 |
DIABETES MELLITUS |
1 |
0.0000 |
| 412 |
PRURITUS |
5 |
0.0000 |
| 413 |
BACK PAIN |
3 |
0.0000 |
| 414 |
ARTHRITIS |
1 |
0.0000 |
| 415 |
DRUG INTERACTION |
2 |
0.0000 |
| 416 |
FEELING ABNORMAL |
3 |
0.0000 |
| 417 |
THROMBOSIS |
1 |
0.0000 |
| 418 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 419 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 420 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 421 |
DEATH |
10 |
0.0000 |
| 422 |
BALANCE DISORDER |
1 |
0.0000 |
| 423 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 424 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 425 |
MALAISE |
5 |
0.0000 |
| 426 |
PAIN |
7 |
0.0000 |
| 427 |
TACHYCARDIA |
1 |
0.0000 |
| 428 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 429 |
ADVERSE EVENT |
1 |
0.0000 |
| 430 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 431 |
WEIGHT DECREASED |
3 |
0.0000 |
| 432 |
DRUG INEFFECTIVE |
14 |
0.0000 |
| 433 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 434 |
MIGRAINE |
1 |
0.0000 |
| 435 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 436 |
CONTUSION |
1 |
0.0000 |
| 437 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 438 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 439 |
SINUSITIS |
1 |
0.0000 |
| 440 |
ERYTHEMA |
2 |
0.0000 |
| 441 |
ARTHRALGIA |
4 |
0.0000 |
| 442 |
HYPERTENSION |
2 |
0.0000 |
| 443 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 444 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 445 |
WEIGHT INCREASED |
2 |
0.0000 |
| 446 |
ASTHMA |
1 |
0.0000 |
| 447 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 448 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 449 |
PALPITATIONS |
1 |
0.0000 |
| 450 |
JOINT SWELLING |
1 |
0.0000 |
| 451 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 452 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 453 |
DIZZINESS |
4 |
0.0000 |
| 454 |
OFF LABEL USE |
7 |
0.0000 |
| 455 |
DRY SKIN |
1 |
0.0000 |
| 456 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 457 |
NEUTROPENIA |
1 |
0.0000 |
| 458 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 459 |
SOMNOLENCE |
1 |
0.0000 |
| 460 |
OVERDOSE |
1 |
0.0000 |
| 461 |
RASH |
2 |
0.0000 |
| 462 |
ANXIETY |
1 |
0.0000 |